Denosumab Chemotherapy for Recurrent Giant-Cell Tumor of Bone: A Case Report of Neoadjuvant Use Enabling Complete Surgical Resection

Figure 4

Sagittal T1 (a) and T2 (b) weighted images show postsurgical changes with no significant residual tumor 7 months after resection.

(a)

(b)